Intestinibacter bartlettii DSM 16795 is an anaerobe bacterium that was isolated from human faecal material.
anaerobe genome sequence 16S sequence Bacteria
SI-ID 134281
| @ref 20215 |
|
Last LPSN update
2026-02-09 11:18:22 |
| Domain Bacteria |
| Phylum Bacillota |
| Class Clostridia |
| Order Peptostreptococcales |
| Family Peptostreptococcaceae |
| Genus Intestinibacter |
| Species Intestinibacter bartlettii |
| Full scientific name Intestinibacter bartlettii (Song et al. 2004) Gerritsen et al. 2014 |
| Synonyms (1) |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 6607 | RCM MEDIUM (N2/CO2) (DSMZ Medium 634c) | Medium recipe at MediaDive  | Name: RCM MEDIUM (N2/CO2) (DSMZ Medium 634c) Composition: dehydrated RCM medium 38.0 g/l Sodium carbonate 1.0 g/l Sodium resazurin 0.0005 g/l Distilled water | ||
| 6607 | CMC MEDIUM (N2/CO2) (DSMZ Medium 110a) | Medium recipe at MediaDive | Name: CMC MEDIUM (N2/CO2) (DSMZ Medium 110a) Composition: Ground beef 500.0 g/l Casitone 30.0 g/l Yeast extract 5.0 g/l K2HPO4 5.0 g/l D-Glucose 4.0 g/l Na2CO3 1.5 g/l Cellobiose 1.0 g/l Maltose 1.0 g/l Starch 1.0 g/l L-Cysteine HCl x H2O 0.5 g/l Sodium resazurin 0.0005 g/l NaOH Distilled water |
| @ref | Growth | Type | Temperature (°C) | |
|---|---|---|---|---|
| 6607 | positive | growth | 37 |
| Cat1 | Cat2 | Cat3 | |
|---|---|---|---|
| #Host | #Human | - | |
| #Host Body Product | #Gastrointestinal tract | #Feces (Stool) |
| @ref | Sample type | Geographic location | Country | Country ISO 3 Code | Continent | |
|---|---|---|---|---|---|---|
| 6607 | human faecal material | Chicago, Rush Childrens Hospital | USA | USA | North America |
Global distribution of 16S sequence AY438672 (>99% sequence identity) for Intestinibacter bartlettii subclade from Microbeatlas 
 Aquatic Samples |
2367 |
 Soil Samples |
540 |
 Animal Samples |
67620 |
 Plant Samples |
219 |
| Total Samples | 70746 |
| @ref | Description | Assembly level | INSDC accession | BV-BRC accession | IMG accession | NCBI tax ID | Score | |
|---|---|---|---|---|---|---|---|---|
| 66792 | ASM2514896v1 assembly for Intestinibacter bartlettii DSM 16795 | complete | GCA_025148965   | 261299.117  | 261299 | 99.8 |  | |
| 66792 | IMG-taxon 2585428074 annotated assembly for Intestinibacter bartlettii DSM 16795 | scaffold | GCA_900167285 | 445973.14 | 2585428074  | 445973 | 71.88 | |
| 66792 | ASM15444v1 assembly for Intestinibacter bartlettii DSM 16795 | scaffold | GCA_000154445 | 445973.7 | 641736113 | 445973 | 70.45 | |
| @ref | Description | Accession | Length | Database | NCBI tax ID | |
|---|---|---|---|---|---|---|
| 6607 | Clostridium bartlettii strain WAL 16138 16S ribosomal RNA gene, partial sequence | AY438672 | 1429 |  | 445973 |
| 6607 | GC-content (mol%)29.8 |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Correlating the Gut Microbiota and Circulating Hormones with Acne Lesion Counts and Skin Biophysical Features. | Sivamani RK, Maloh J, Nong Y. | Microorganisms | 10.3390/microorganisms11082049 | 2023 | | |
| Comprehensive analysis of vaginal microbiota, metabolites, and inflammatory factors in preterm and term pregnancies. | Shen LP, Cai BJ, Guan JX, Peng T, Jin L. | Front Microbiol | 10.3389/fmicb.2025.1689494 | 2025 | | |
| The Role of the Gut Microbiome and Microbial Dysbiosis in Common Skin Diseases. | Rygula I, Pikiewicz W, Grabarek BO, Wojcik M, Kaminiow K. | Int J Mol Sci | 10.3390/ijms25041984 | 2024 | | |
| Metabolism | A Diverse Range of Human Gut Bacteria Have the Potential To Metabolize the Dietary Component Gallic Acid. | Esteban-Torres M, Santamaria L, Cabrera-Rubio R, Plaza-Vinuesa L, Crispie F, de Las Rivas B, Cotter P, Munoz R. | Appl Environ Microbiol | 10.1128/aem.01558-18 | 2018 | |
| Breastfeeding and the major fermentation metabolite lactate determine occurrence of Peptostreptococcaceae in infant feces. | Huertas-Diaz L, Kyhnau R, Ingribelli E, Neuzil-Bunesova V, Li Q, Sasaki M, Lauener RP, Roduit C, Frei R, Study Group CC, Sundekilde U, Schwab C. | Gut Microbes | 10.1080/19490976.2023.2241209 | 2023 | | |
| Synthesis and Degradation of the Phytohormone Indole-3-Acetic Acid by the Versatile Bacterium Paraburkholderia xenovorans LB400 and Its Growth Promotion of Nicotiana tabacum Plant. | Vega-Celedon P, Castillo-Novales D, Bravo G, Cardenas F, Romero-Silva MJ, Seeger M. | Plants (Basel) | 10.3390/plants13243533 | 2024 | | |
| Genetics | Understanding the Representative Gut Microbiota Dysbiosis in Metformin-Treated Type 2 Diabetes Patients Using Genome-Scale Metabolic Modeling. | Rosario D, Benfeitas R, Bidkhori G, Zhang C, Uhlen M, Shoaie S, Mardinoglu A. | Front Physiol | 10.3389/fphys.2018.00775 | 2018 | |
| The Exopolysaccharide Cepacian Plays a Role in the Establishment of the Paraburkholderia phymatum - Phaseolus vulgaris Symbiosis. | Liu Y, Bellich B, Hug S, Eberl L, Cescutti P, Pessi G. | Front Microbiol | 10.3389/fmicb.2020.01600 | 2020 | | |
| Metabolism | A metagenomic beta-glucuronidase uncovers a core adaptive function of the human intestinal microbiome. | Gloux K, Berteau O, El Oumami H, Beguet F, Leclerc M, Dore J. | Proc Natl Acad Sci U S A | 10.1073/pnas.1000066107 | 2011 | |
| Mapping the T cell repertoire to a complex gut bacterial community. | Nagashima K, Zhao A, Atabakhsh K, Bae M, Blum JE, Weakley A, Jain S, Meng X, Cheng AG, Wang M, Higginbottom S, Dimas A, Murugkar P, Sattely ES, Moon JJ, Balskus EP, Fischbach MA. | Nature | 10.1038/s41586-023-06431-8 | 2023 | | |
| Genetics | PAAR Proteins Are Versatile Clips That Enrich the Antimicrobial Weapon Arsenals of Prokaryotes. | Zhang Z, Liu Y, Zhang P, Wang J, Li D, Li YZ. | mSystems | 10.1128/msystems.00953-21 | 2021 | |
| Evolutionary dynamics of Clostridium difficile over short and long time scales. | He M, Sebaihia M, Lawley TD, Stabler RA, Dawson LF, Martin MJ, Holt KE, Seth-Smith HM, Quail MA, Rance R, Brooks K, Churcher C, Harris D, Bentley SD, Burrows C, Clark L, Corton C, Murray V, Rose G, Thurston S, van Tonder A, Walker D, Wren BW, Dougan G, Parkhill J. | Proc Natl Acad Sci U S A | 10.1073/pnas.0914322107 | 2010 | | |
| Phylogeny | Assessing the impact of broiler genotype on cecal and tracheal microbiome composition using full-length 16S rRNA sequencing. | Poudel S, Rahman FA, Granados EAF, Adhikari Y, Naeem M, Rochell SJ, Bourassa D. | Poult Sci | 10.1016/j.psj.2025.106072 | 2025 | |
| Causal association between gut microbiota composition and the risk of atrial fibrillation. | Tan J, Wang J, Yang Y, Zhu J, Wang L, Xu W, Lyu S, Wu S, Wang J, Zhang H. | J Transl Int Med | 10.1515/jtim-2025-0031 | 2025 | | |
| Multi-omics study reveals gut microbiota dysbiosis and tryptophan metabolism alterations in GH-PitNET progression. | Liu J, Ye Z, Zhang Y, You S, Sun S, Lu L, Su W, Liu J, Pu J, Pan H, Zhu H, Deng K, Yao Y, Hu X, Zhang S. | Sci Rep | 10.1038/s41598-025-07812-x | 2025 | | |
| Enzymology | Influence of the gut microbiota on the pharmacokinetics of tacrolimus in liver transplant recipients: insights from microbiome analysis. | Wang Y, Bai Z, Liu Y, Wang Y, Xu J, Lai Z. | Front Microbiol | 10.3389/fmicb.2025.1616985 | 2025 | |
| Microbial metabolism mediates the deteriorative effects of sedentary behaviour on insulin resistance. | Ju J, He J, Ye B, Li S, Zhao J, Chen W, Zhang Q, Zhao W, Yang J, Liu L, Li Y, Xia M, Liu Y. | Clin Transl Med | 10.1002/ctm2.70348 | 2025 | | |
| Decoding the Gut Microbiota in Multiple Sclerosis Using Nanopore Long-Read Sequencing: Insights into Disease Severity and Subtypes. | Alshinnawy AS, Badiea EA, Swelam MS, Sayed AA, Mohamed MR. | Mol Neurobiol | 10.1007/s12035-025-05194-9 | 2025 | | |
| A Mesophilic Argonaute from Cohnella algarum Mediates Programmable DNA/RNA Cleavage with Distinctive Guide Specificity. | Peng Y, Pan W, Wang Y, Liu Y, Ma L. | Biomolecules | 10.3390/biom15101459 | 2025 | | |
| Alterations in Gut Microbiota and Their Correlation with Brain Beta-Amyloid Burden Measured by 18F-Florbetaben PET in Mild Cognitive Impairment Due to Alzheimer's Disease. | Kim GH, Kim BR, Yoon HJ, Jeong JH. | J Clin Med | 10.3390/jcm13071944 | 2024 | | |
| Culture-dependent screening of endospore-forming clostridia in infant feces. | Ingribelli E, Modrackova N, Tejnecky V, Killer J, Schwab C, Neuzil-Bunesova V. | BMC Microbiol | 10.1186/s12866-023-03104-4 | 2023 | | |
| Influence of gut microbiota and immune markers in different stages of colorectal adenomas. | Wang X, Chen H, Yang M, Huang M, Zhang D, Li M, Wang H, Zhou Q, Lu L, Li Y, Yu J, Ma L. | Front Microbiol | 10.3389/fmicb.2025.1556056 | 2025 | | |
| Risk factors associated with immune-related severe adverse events in patients with cancer: A scoping review. | Su Z, Zhang L, Lian X, Wang Y. | Asia Pac J Oncol Nurs | 10.1016/j.apjon.2025.100661 | 2025 | | |
| Genetics | A metagenome-wide association study of gut microbiota in hepatitis B virus-related cirrhosis in northwest China. | Feng M, Chai Y, Li J, Wang Q, Zhang D. | Front Genet | 10.3389/fgene.2025.1619911 | 2025 | |
| Fecal microbiome analysis in patients with metabolic syndrome and type 2 diabetes. | Sinisterra Loaiza LI, Fernandez-Edreira D, Linares-Blanco J, Cepeda A, Cardelle-Cobas A, Fernandez-Lozano C. | PeerJ | 10.7717/peerj.19108 | 2025 | | |
| Enzymology | Linking the gut microbiota to persistent symptoms in survivors of COVID-19 after discharge. | Zhou Y, Zhang J, Zhang D, Ma WL, Wang X. | J Microbiol | 10.1007/s12275-021-1206-5 | 2021 | |
| Associations of gut microbiota with disease development, disease activity, and therapeutic effects in patients with systemic lupus erythematosus. | Nishio J, Sato H, Watanabe E, Masuoka H, Aoki K, Kawazoe M, Wakiya R, Yamada S, Muraoka S, Masuoka S, Hayashi T, Mizutani S, Yamada Z, Koshiba K, Irita I, Kanaji M, Furukawa K, Yajima N, Dobashi H, Hirose W, Ishii Y, Suda W, Nanki T. | Sci Rep | 10.1038/s41598-024-83835-0 | 2024 | | |
| Association of Mucin-Degrading Gut Microbiota and Dietary Patterns with Colonic Transit Time in Constipation: A Secondary Analysis of a Randomized Clinical Trial. | Wu X, Yang HJ, Ryu MS, Jung SJ, Ha K, Jeong DY, Park S. | Nutrients | 10.3390/nu17010138 | 2024 | | |
| Random guide-independent DNA cleavage from the Argonaute of Exiguobacterium sp. AB2. | Caniza MAM, Dy RLV. | BMC Microbiol | 10.1186/s12866-025-04159-1 | 2025 | | |
| Phenotype | Stratification of Gut Microbiota Profiling Based on Autism Neuropsychological Assessments. | Marangelo C, Vernocchi P, Del Chierico F, Scanu M, Marsiglia R, Petrolo E, Fuca E, Guerrera S, Valeri G, Vicari S, Putignani L. | Microorganisms | 10.3390/microorganisms12102041 | 2024 | |
| Genetics | Gut microbiota remodeling and sensory-emotional functional disruption in adolescents with bipolar depression. | Tang A, Chen Y, Ding J, Li Z, Xu C, Hu S, Lai J. | J Transl Med | 10.1186/s12967-025-07152-4 | 2025 | |
| Effect of acarbose and vildagliptin on plasma trimethylamine N-oxide levels in patients with type 2 diabetes mellitus: a 6-month, two-arm randomized controlled trial. | Yang X, Zhang X, Sun C, Zhao C, Kong X, Zhao M, Ji L, Li Y. | Front Endocrinol (Lausanne) | 10.3389/fendo.2025.1575087 | 2025 | | |
| Phylogeny | Dynamics of the gut microbiome in subjects challenged with Shigella sonnei 53G in a controlled human infection model. | Liechty Z, Baldwin A, Isidean S, Suvarnapunya A, Frenck R, Porter C, Goodson M. | mSphere | 10.1128/msphere.00906-24 | 2025 | |
| Novel cross-feeding human gut microbes metabolizing tryptophan to indole-3-propionate. | Zund JN, Mujezinovic D, Reichlin M, Pluss S, Caflisch M, Robinson S, Lacroix C, Pugin B. | Gut Microbes | 10.1080/19490976.2025.2501195 | 2025 | | |
| Metabolic modelling of the human gut microbiome in type 2 diabetes patients in response to metformin treatment. | Ezzamouri B, Rosario D, Bidkhori G, Lee S, Uhlen M, Shoaie S. | NPJ Syst Biol Appl | 10.1038/s41540-022-00261-6 | 2023 | | |
| Genetics | Profiling and comprehensive analysis of microbiome and ARGs of nurses and nursing workers in China: a cross-sectional study. | Liu Y, Wang F, Zhou Z, Liu B, Wu Z, Pan X. | Sci Rep | 10.1038/s41598-024-82659-2 | 2024 | |
| Insight into gut dysbiosis of patients with inflammatory bowel disease and ischemic colitis. | Dahal RH, Kim S, Kim YK, Kim ES, Kim J. | Front Microbiol | 10.3389/fmicb.2023.1174832 | 2023 | | |
| Genetics | Causal relationship between gut microbiota and Behçet's disease: a Mendelian randomization study. | Li YN, Chen T, Xue Y, Jia JY, Yan TK, Xu PC. | Front Microbiol | 10.3389/fmicb.2024.1416614 | 2024 | |
| Phylogeny | How Hydroxyurea Alters the Gut Microbiome: A Longitudinal Study Involving Angolan Children with Sickle Cell Anemia. | Delgadinho M, Ginete C, Santos B, Fernandes C, Silva C, Miranda A, Vasconcelos JN, Brito M. | Int J Mol Sci | 10.3390/ijms23169061 | 2022 | |
| Specific Bacterial Co-abundance Groups Are Associated With Inflammatory Status in Patients With Ulcerative Colitis. | Jangi S, Zhao N, Hsia K, Park YS, Michaud DS, Yoon H. | J Crohns Colitis | 10.1093/ecco-jcc/jjae125 | 2025 | | |
| Gut Microbiome and Cytokine Profiles in Post-COVID Syndrome. | Mussabay K, Kozhakhmetov S, Dusmagambetov M, Mynzhanova A, Nurgaziyev M, Jarmukhanov Z, Vinogradova E, Dusmagambetova A, Daulbaeva A, Chulenbayeva L, Tauekelova A, Bekbossynova M, Kushugulova A. | Viruses | 10.3390/v16050722 | 2024 | | |
| Pathogenicity | Virulence Factors of the Gut Microbiome Are Associated with BMI and Metabolic Blood Parameters in Children with Obesity. | Murga-Garrido SM, Ulloa-Perez EJ, Diaz-Benitez CE, Orbe-Orihuela YC, Cornejo-Granados F, Ochoa-Leyva A, Sanchez-Flores A, Cruz M, Castaneda-Marquez AC, Plett-Torres T, Burguete Garcia AI, Lagunas-Martinez A. | Microbiol Spectr | 10.1128/spectrum.03382-22 | 2023 | |
| Effects of kefir on symptoms, sleep, and gut microbiota in children with ADHD: a randomised controlled trial. | Lawrence K, Fibert P, Toribio-Mateas M, Gregory AM, Hobbs J, Quadt F, Wright S, Cotter PD, Patel S, Myrissa K. | BMC Psychiatry | 10.1186/s12888-025-07568-8 | 2025 | | |
| Discovery of robust and highly specific microbiome signatures of non-alcoholic fatty liver disease. | Nychas E, Marfil-Sanchez A, Chen X, Mirhakkak M, Li H, Jia W, Xu A, Nielsen HB, Nieuwdorp M, Loomba R, Ni Y, Panagiotou G. | Microbiome | 10.1186/s40168-024-01990-y | 2025 | | |
| Association of distinct microbial and metabolic signatures with microscopic colitis. | Chen AS, Kim H, Nzabarushimana E, Shen J, Williams K, Gurung J, McGoldrick J, Burke KE, Yarze JC, Nguyen LH, Staller K, Chung DC, Xavier RJ, Khalili H. | Nat Commun | 10.1038/s41467-025-59566-9 | 2025 | | |
| Effects of Italian Mediterranean Organic Diet on the Gut Microbiota: A Pilot Comparative Study with Conventional Products and Free Diet. | Di Renzo L, Frank G, Pala B, Cianci R, La Placa G, Raffaelli G, Palma R, Peluso D, De Lorenzo A, Gualtieri P, On Behalf Of Clinical Nutrition And Nutrigenomics Project Group. | Microorganisms | 10.3390/microorganisms13071694 | 2025 | | |
| Pathogenicity | Toxic microbiome and progression of chronic kidney disease: insights from a longitudinal CKD-Microbiome Study. | Laiola M, Koppe L, Larabi A, Thirion F, Lange C, Quinquis B, David A, Le Chatelier E, Benoit B, Sequino G, Chanon S, Vieille-Marchiset A, Herpe YE, Alvarez JC, Glorieux G, Krukowski H, Huys GR, Raes J, Fouque D, Massy ZA, Ehrlich SD, Stengel B, Wagner S, CKD-REIN Study collaborators. | Gut | 10.1136/gutjnl-2024-334634 | 2025 | |
| The microbiome in post-acute infection syndrome (PAIS). | Guo C, Yi B, Wu J, Lu J. | Comput Struct Biotechnol J | 10.1016/j.csbj.2023.08.002 | 2023 | | |
| Gut microbiota alterations are associated with functional outcomes in patients of acute ischemic stroke with non-alcoholic fatty liver disease. | Yu G, Chen Q, Chen J, Liao X, Xie H, Zhao Y, Liu J, Sun J, Chen S. | Front Neurosci | 10.3389/fnins.2023.1327499 | 2023 | | |
| Gut Microbiota Dysbiosis Associated With Altered Production of Short Chain Fatty Acids in Children With Neurodevelopmental Disorders. | Bojovic K, Ignjatovic DI, Sokovic Bajic S, Vojnovic Milutinovic D, Tomic M, Golic N, Tolinacki M. | Front Cell Infect Microbiol | 10.3389/fcimb.2020.00223 | 2020 | | |
| Serum metabolome and gut microbiome alterations are associated with low handgrip strength in older adults. | Guo Y, Wang Q, Lv Y, Xia F, Chen X, Mao Y, Wang X, Ding G, Yu J. | Aging (Albany NY) | 10.18632/aging.205501 | 2024 | | |
| Personalized prediction of glycemic responses to food in women with diet-treated gestational diabetes: the role of the gut microbiota. | Popova PV, Isakov AO, Rusanova AN, Sitkin SI, Anopova AD, Vasukova EA, Tkachuk AS, Nemikina IS, Stepanova EA, Eriskovskaya AI, Stepanova EA, Pustozerov EA, Kokina MA, Vasilieva EY, Vasilyeva LB, Zgairy S, Rubin E, Even C, Turjeman S, Pervunina TM, Grineva EN, Koren O, Shlyakhto EV. | NPJ Biofilms Microbiomes | 10.1038/s41522-025-00650-9 | 2025 | | |
| Analyzing Type 2 Diabetes Associations with the Gut Microbiome in Individuals from Two Ethnic Backgrounds Living in the Same Geographic Area. | Balvers M, Deschasaux M, van den Born BJ, Zwinderman K, Nieuwdorp M, Levin E. | Nutrients | 10.3390/nu13093289 | 2021 | | |
| Gut microbiota differences in five-year-old children that were born preterm with a history of necrotizing enterocolitis: A pilot trial. | Magnusson A, Jabbari Shiadeh SM, Ardalan M, Swolin-Eide D, Elfvin A. | iScience | 10.1016/j.isci.2024.110325 | 2024 | | |
| Alterations in colorectal cancer virome and its persistence after surgery. | Ho SX, Law JH, Png CW, Alberts R, Zhang Y, Chu JJH, Tan KK. | Sci Rep | 10.1038/s41598-024-53041-z | 2024 | | |
| [Dysbiosis of Gut Microbiota in Patients with Post-Stroke Cognitive Impairment]. | Feng RJ, Yu Q, Li Y, Feng D, Li YM. | Sichuan Da Xue Xue Bao Yi Xue Ban | 10.12182/20211160507 | 2021 | | |
| Increased abundance of Ruminococcus gnavus in gut microbiota is associated with moyamoya disease and non-moyamoya intracranial large artery disease. | Mineharu Y, Nakamura Y, Sato N, Kamata T, Oichi Y, Fujitani T, Funaki T, Okuno Y, Miyamoto S, Koizumi A, Harada KH. | Sci Rep | 10.1038/s41598-022-24496-9 | 2022 | | |
| Bifidobacterium animalis Probio-M8 improves sarcopenia physical performance by mitigating creatine restrictions imposed by microbial metabolites. | Zhang Z, Fang Y, He Y, Farag MA, Zeng M, Sun Y, Peng S, Jiang S, Zhang X, Chen K, Xu M, Han Z, Zhang J. | NPJ Biofilms Microbiomes | 10.1038/s41522-024-00618-1 | 2024 | | |
| Vitamin C Supplementation in Healthy Individuals Leads to Shifts of Bacterial Populations in the Gut-A Pilot Study. | Otten AT, Bourgonje AR, Peters V, Alizadeh BZ, Dijkstra G, Harmsen HJM. | Antioxidants (Basel) | 10.3390/antiox10081278 | 2021 | | |
| Yeast mannan rich fraction positively influences microbiome uniformity, productivity associated taxa, and lay performance. | Leigh RJ, Corrigan A, Murphy RA, Taylor-Pickard J, Moran CA, Walsh F. | Anim Microbiome | 10.1186/s42523-024-00295-7 | 2024 | | |
| Genetics | Gut microbiome and mycobiome in inflammatory bowel disease patients with Clostridioides difficile infection. | Yu S, Ge X, Xu H, Tan B, Tian B, Shi Y, Dai Y, Li Y, Hu S, Qian J. | Front Cell Infect Microbiol | 10.3389/fcimb.2023.1129043 | 2023 | |
| The Influence of Gut Microbial Species on Diabetes Mellitus. | Al-Ishaq RK, Samuel SM, Busselberg D. | Int J Mol Sci | 10.3390/ijms24098118 | 2023 | | |
| Phylogeny | Gut Microbiota Associated with Clostridioides difficile Carriage in Three Clinical Groups (Inflammatory Bowel Disease, C. difficile Infection and Healthcare Workers) in Hospital Field. | Martinez E, Crevecoeur S, Thirion C, Grandjean J, Fall PA, Hayette MP, Michel M, Taminiau B, Louis E, Daube G. | Microorganisms | 10.3390/microorganisms11102527 | 2023 | |
| Bibliometrics and visual analysis of metformin and gut microbiota from 2012 to 2022: A systematic review. | Shu Y, Shu Y, Li W, Hu Q, Xiong D. | Medicine (Baltimore) | 10.1097/md.0000000000036478 | 2023 | | |
| Pathogenicity | Microbial-derived imidazole propionate links the heart failure-associated microbiome alterations to disease severity. | Raju SC, Molinaro A, Awoyemi A, Jorgensen SF, Braadland PR, Nendl A, Seljeflot I, Ueland PM, McCann A, Aukrust P, Vestad B, Mayerhofer C, Broch K, Gullestad L, Lappegard KT, Halvorsen B, Kristiansen K, Hov JR, Troseid M. | Genome Med | 10.1186/s13073-024-01296-6 | 2024 | |
| Metformin Affects Gut Microbiome Composition and Function and Circulating Short-Chain Fatty Acids: A Randomized Trial. | Mueller NT, Differding MK, Zhang M, Maruthur NM, Juraschek SP, Miller ER, Appel LJ, Yeh HC. | Diabetes Care | 10.2337/dc20-2257 | 2021 | | |
| Metabolism | Culture dependent and independent analyses suggest a low level of sharing of endospore-forming species between mothers and their children. | Avershina E, Larsen MG, Aspholm M, Lindback T, Storro O, Oien T, Johnsen R, Rudi K. | Sci Rep | 10.1038/s41598-020-58858-y | 2020 | |
| Genetics | Catalytically active prokaryotic Argonautes employ phospholipase D family proteins to strengthen immunity against different genetic invaders. | Cheng F, Wu A, Li Z, Xu J, Cao X, Yu H, Liu Z, Wang R, Han W, Xiang H, Li M. | mLife | 10.1002/mlf2.12138 | 2024 | |
| Bacteroides uniformis-generated hexadecanedioic acid ameliorates metabolic-associated fatty liver disease. | Zhang DY, Li D, Chen SJ, Zhang LJ, Zhu XL, Chen FD, Chen C, Wang Q, Du Y, Xiong JX, Huang SM, Zhang XD, Lv YT, Zeng F, Chen RX, Huang X, Mao F, Zhou S, Yao Q, Huang Y, Chen R, Mo Y, Xie Y, Jiang YH, Chen Z, Mo CY, Chen JJ, Bai FH. | Gut Microbes | 10.1080/19490976.2025.2508433 | 2025 | | |
| New Insights into the Diurnal Rhythmicity of Gut Microbiota and Its Crosstalk with Host Circadian Rhythm. | Wang H, Zhang H, Su Y. | Animals (Basel) | 10.3390/ani12131677 | 2022 | | |
| Fecal Microbiome and Metabolomic Profiles of Mixed-Fed Infants Are More Similar to Formula-Fed than Breastfed Infants. | Wang M, Valizadegan N, Fields CJ, Donovan SM. | Microorganisms | 10.3390/microorganisms13010166 | 2025 | | |
| Genetics | Profiling of the intestinal community of Clostridia: taxonomy and evolutionary analysis. | Candeliere F, Musmeci E, Amaretti A, Sola L, Raimondi S, Rossi M. | Microbiome Res Rep | 10.20517/mrr.2022.19 | 2023 | |
| Beneficial Effects of Probiotic Lactobacillus paraplantarum BGCG11 on Pancreatic and Duodenum Function in Diabetic Rats. | Mihailovic M, Sokovic Bajic S, Arambasic Jovanovic J, Brdaric E, Dinic S, Grdovic N, Uskokovic A, Rajic J, Dordevic M, Tolinacki M, Golic N, Zivkovic M, Vidakovic M. | Int J Mol Sci | 10.3390/ijms25147697 | 2024 | | |
| Genetics | Correlation of the gut microbiome and immune-related adverse events in gastrointestinal cancer patients treated with immune checkpoint inhibitors. | Zhang Y, Cheng S, Zou H, Han Z, Xie T, Zhang B, Dai D, Yin X, Liang Y, Kou Y, Tan Y, Shen L, Peng Z. | Front Cell Infect Microbiol | 10.3389/fcimb.2023.1099063 | 2023 | |
| The gut-microbiota-brain axis in a Spanish population in the aftermath of the COVID-19 pandemic: microbiota composition linked to anxiety, trauma, and depression profiles. | Malan-Muller S, Valles-Colomer M, Palomo T, Leza JC. | Gut Microbes | 10.1080/19490976.2022.2162306 | 2023 | | |
| Phenotype | Compositional changes in fecal microbiota associated with clinical phenotypes and prognosis in Korean patients with inflammatory bowel disease. | Shin SY, Kim Y, Kim WS, Moon JM, Lee KM, Jung SA, Park H, Huh EY, Kim BC, Lee SC, Choi CH, IBD Research Group of the Korean Association for the Study of Intestinal Diseases. | Intest Res | 10.5217/ir.2021.00168 | 2023 | |
| A programmable pAgo nuclease with RNA target-cleavage specificity from the mesophilic bacterium Verrucomicrobia. | Liu Q, Chen W, Zhang Y, Hu F, Jiang X, Wang F, Liu Y, Ma L. | Acta Biochim Biophys Sin (Shanghai) | 10.3724/abbs.2023110 | 2023 | | |
| Dietary Live Yeast Supplementation Influence on Cow's Milk, Teat and Bedding Microbiota in a Grass-Diet Dairy System. | Verdier-Metz I, Delbes C, Bouchon M, Rifa E, Theil S, Chaucheyras-Durand F, Chevaux E, Duniere L, Chassard C. | Microorganisms | 10.3390/microorganisms11030673 | 2023 | | |
| Phylogeny | Development of a Novel Metagenomic Biomarker for Prediction of Upper Gastrointestinal Tract Involvement in Patients With Crohn's Disease. | Kwak MS, Cha JM, Shin HP, Jeon JW, Yoon JY. | Front Microbiol | 10.3389/fmicb.2020.01162 | 2020 | |
| Characterization of Argonaute nucleases from mesophilic bacteria Paenibacillus borealis and Brevibacillus laterosporus. | Dong H, Huang F, Guo X, Xu X, Liu Q, Li X, Feng Y. | Bioresour Bioprocess | 10.1186/s40643-021-00478-z | 2021 | | |
| Human microbiome in post-acute COVID-19 syndrome (PACS). | Fallah A, Sedighian H, Kachuei R, Fooladi AAI. | Curr Res Microb Sci | 10.1016/j.crmicr.2024.100324 | 2025 | | |
| Phylogeny | Meta-Analysis Reveals Compositional and Functional Microbial Changes Associated with Osteoporosis. | Akinsuyi OS, Roesch LFW. | Microbiol Spectr | 10.1128/spectrum.00322-23 | 2023 | |
| NAPTUNE: nucleic acids and protein biomarkers testing via ultra-sensitive nucleases escalation. | Hu T, Ke X, Yu Y, Feng H, Zhang S, Cui Y, Zhang B, He M, Tang Y, Liu L, Lin Y, Ji Q, Chen C, Xu C, Hu C. | Nat Commun | 10.1038/s41467-025-56653-9 | 2025 | | |
| Model Selection Reveals the Butyrate-Producing Gut Bacterium Coprococcus eutactus as Predictor for Language Development in 3-Year-Old Rural Ugandan Children. | Kort R, Schlosser J, Vazquez AR, Atukunda P, Muhoozi GKM, Wacoo AP, Sybesma WFH, Westerberg AC, Iversen PO, Schoen ED. | Front Microbiol | 10.3389/fmicb.2021.681485 | 2021 | | |
| Maternal antibiotic prophylaxis during cesarean section has a limited impact on the infant gut microbiome. | Sinha T, Prins JR, Fernandez-Pato A, Kruk M, Dierikx T, de Meij T, de Boer M, de Boer JF, Scherjon S, Kurilshikov A, Zhernakova A. | Cell Host Microbe | 10.1016/j.chom.2024.07.010 | 2024 | | |
| Breast cancer patients from the Midwest region of the United States have reduced levels of short-chain fatty acid-producing gut bacteria. | Shrode RL, Knobbe JE, Cady N, Yadav M, Hoang J, Cherwin C, Curry M, Garje R, Vikas P, Sugg S, Phadke S, Filardo E, Mangalam AK. | Sci Rep | 10.1038/s41598-023-27436-3 | 2023 | | |
| Fucose modifies short chain fatty acid and H2S formation through alterations of microbial cross-feeding activities. | Hogsgaard K, Vidal NP, Marietou A, Fiehn OG, Li Q, Bechtner J, Catalano J, Martinez MM, Schwab C. | FEMS Microbiol Ecol | 10.1093/femsec/fiad107 | 2023 | | |
| A Pilot Study Exploring the Association of Entacapone, Gut Microbiota, and the Subsequent Side Effects in Patients With Parkinson's Disease. | Fu SC, Lee CH, Hsieh YC, Wu PH, Lin SH, Wang H. | Front Cell Infect Microbiol | 10.3389/fcimb.2022.837019 | 2022 | | |
| Crosstalk between the gut microbiome and clinical response in locally advanced thoracic esophageal squamous cell carcinoma during neoadjuvant camrelizumab and chemotherapy. | Xu L, Qi Y, Jiang Y, Ji Y, Zhao Q, Wu J, Lu W, Wang Y, Chen Q, Wang C. | Ann Transl Med | 10.21037/atm-22-1165 | 2022 | | |
| Pathogenicity | Unmasking Pandemic Echoes: An In-Depth Review of Long COVID's Unabated Cardiovascular Consequences beyond 2020. | Luchian ML, Higny J, Benoit M, Robaye B, Berners Y, Henry JP, Colle B, Xhaet O, Blommaert D, Droogmans S, Motoc AI, Cosyns B, Gabriel L, Guedes A, Demeure F. | Diagnostics (Basel) | 10.3390/diagnostics13213368 | 2023 | |
| Cardiovascular Benefits of Empagliflozin Are Associated With Gut Microbiota and Plasma Metabolites in Type 2 Diabetes. | Deng X, Zhang C, Wang P, Wei W, Shi X, Wang P, Yang J, Wang L, Tang S, Fang Y, Liu Y, Chen Y, Zhang Y, Yuan Q, Shang J, Kan Q, Yang H, Man H, Wang D, Yuan H. | J Clin Endocrinol Metab | 10.1210/clinem/dgac210 | 2022 | | |
| Pathogenicity | Metformin and Breast Cancer: Current Findings and Future Perspectives from Preclinical and Clinical Studies. | Corleto KA, Strandmo JL, Giles ED. | Pharmaceuticals (Basel) | 10.3390/ph17030396 | 2024 | |
| Guild-Level Microbiome Signature Associated with COVID-19 Severity and Prognosis. | Guo M, Wu G, Tan Y, Li Y, Jin X, Qi W, Guo X, Zhang C, Zhu Z, Zhao L. | mBio | 10.1128/mbio.03519-22 | 2023 | | |
| Gut microbiota diversity and composition in predicting immunotherapy response and immunotherapy-related colitis in melanoma patients: A systematic review. | Oey O, Liu YY, Sunjaya AF, Simadibrata DM, Khattak MA, Gray E. | World J Clin Oncol | 10.5306/wjco.v13.i11.929 | 2022 | | |
| An online atlas of human plasma metabolite signatures of gut microbiome composition. | Dekkers KF, Sayols-Baixeras S, Baldanzi G, Nowak C, Hammar U, Nguyen D, Varotsis G, Brunkwall L, Nielsen N, Eklund AC, Bak Holm J, Nielsen HB, Ottosson F, Lin YT, Ahmad S, Lind L, Sundstrom J, Engstrom G, Smith JG, Arnlov J, Orho-Melander M, Fall T. | Nat Commun | 10.1038/s41467-022-33050-0 | 2022 | | |
| A network perspective on the ecology of gut microbiota and progression of type 2 diabetes: Linkages to keystone taxa in a Mexican cohort. | Esquivel-Hernandez DA, Martinez-Lopez YE, Sanchez-Castaneda JP, Neri-Rosario D, Padron-Manrique C, Giron-Villalobos D, Mendoza-Ortiz C, Resendis-Antonio O. | Front Endocrinol (Lausanne) | 10.3389/fendo.2023.1128767 | 2023 | | |
| Programmable cleavage of linear double-stranded DNA by combined action of Argonaute CbAgo from Clostridium butyricum and nuclease deficient RecBC helicase from E. coli. | Vaiskunaite R, Vainauskas J, Morris JJL, Potapov V, Bitinaite J. | Nucleic Acids Res | 10.1093/nar/gkac229 | 2022 | | |
| A conserved switch controls virulence, sporulation, and motility in C. difficile. | DiCandia MA, Edwards AN, Alcaraz YB, Monteiro MP, Lee CD, Vargas Cuebas G, Bagchi P, McBride SM. | PLoS Pathog | 10.1371/journal.ppat.1012224 | 2024 | | |
| Changes in the Intestinal Microbiota of Patients with Inflammatory Bowel Disease with Clinical Remission during an 8-Week Infliximab Infusion Cycle. | Seong G, Kim N, Joung JG, Kim ER, Chang DK, Chun J, Hong SN, Kim YH. | Microorganisms | 10.3390/microorganisms8060874 | 2020 | | |
| Gut microbiota in the pathogenesis and therapeutic approaches of diabetes. | Crudele L, Gadaleta RM, Cariello M, Moschetta A. | EBioMedicine | 10.1016/j.ebiom.2023.104821 | 2023 | | |
| Genetics | The gut microbiota and diabetes: research, translation, and clinical applications - 2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum. | Byndloss M, Devkota S, Duca F, Niess JH, Nieuwdorp M, Orho-Melander M, Sanz Y, Tremaroli V, Zhao L. | Diabetologia | 10.1007/s00125-024-06198-1 | 2024 | |
| The Gut Microbiota and Diabetes: Research, Translation, and Clinical Applications-2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum. | Byndloss M, Devkota S, Duca F, Hendrik Niess J, Nieuwdorp M, Orho-Melander M, Sanz Y, Tremaroli V, Zhao L. | Diabetes Care | 10.2337/dci24-0052 | 2024 | | |
| Gut microbiota-mediated associations of green tea and catechin intakes with glucose metabolism in individuals without type 2 diabetes mellitus: a four-season observational study with mediation analysis. | Ito A, Matsui Y, Takeshita M, Katashima M, Goto C, Kuriki K. | Arch Microbiol | 10.1007/s00203-023-03522-y | 2023 | | |
| Genetics | Alterations of the Gut Microbiota in Patients with Diabetic Nephropathy. | Zhang L, Wang Z, Zhang X, Zhao L, Chu J, Li H, Sun W, Yang C, Wang H, Dai W, Yan S, Chen X, Xu D. | Microbiol Spectr | 10.1128/spectrum.00324-22 | 2022 | |
| Effects of the Lipid Profile, Type 2 Diabetes and Medication on the Metabolic Syndrome-Associated Gut Microbiome. | Gradisteanu Pircalabioru G, Liaw J, Gundogdu O, Corcionivoschi N, Ilie I, Oprea L, Musat M, Chifiriuc MC. | Int J Mol Sci | 10.3390/ijms23147509 | 2022 | | |
| Pathobionts in the tumour microbiota predict survival following resection for colorectal cancer. | Alexander JL, Posma JM, Scott A, Poynter L, Mason SE, Doria ML, Herendi L, Roberts L, McDonald JAK, Cameron S, Hughes DJ, Liska V, Susova S, Soucek P, der Sluis VH, Gomez-Romero M, Lewis MR, Hoyles L, Woolston A, Cunningham D, Darzi A, Gerlinger M, Goldin R, Takats Z, Marchesi JR, Teare J, Kinross J. | Microbiome | 10.1186/s40168-023-01518-w | 2023 | | |
| Phylogeny | Fine-scale spatial variation shape fecal microbiome diversity and composition in black-tailed prairie dogs (Cynomys ludovicianus). | Neha SA, Salazar-Bravo J. | BMC Microbiol | 10.1186/s12866-023-02778-0 | 2023 | |
| Genetics | Dysbiosis and relapse-related microbiome in inflammatory bowel disease: A shotgun metagenomic approach. | Serrano-Gomez G, Mayorga L, Oyarzun I, Roca J, Borruel N, Casellas F, Varela E, Pozuelo M, Machiels K, Guarner F, Vermeire S, Manichanh C. | Comput Struct Biotechnol J | 10.1016/j.csbj.2021.11.037 | 2021 | |
| Noise reduction strategies in metagenomic chromosome confirmation capture to link antibiotic resistance genes to microbial hosts. | McCallum GE, Rossiter AE, Quraishi MN, Iqbal TH, Kuehne SA, van Schaik W. | Microb Genom | 10.1099/mgen.0.001030 | 2023 | | |
| Recent Advances in the Physicochemical Properties and Biotechnological Application of Vitreoscilla Hemoglobin. | Yu F, Zhao X, Wang Z, Liu L, Yi L, Zhou J, Li J, Chen J, Du G. | Microorganisms | 10.3390/microorganisms9071455 | 2021 | | |
| Impacts of dietary exposure to pesticides on faecal microbiome metabolism in adult twins. | Mesnage R, Bowyer RCE, El Balkhi S, Saint-Marcoux F, Gardere A, Ducarmon QR, Geelen AR, Zwittink RD, Tsoukalas D, Sarandi E, Paramera EI, Spector T, Steves CJ, Antoniou MN. | Environ Health | 10.1186/s12940-022-00860-0 | 2022 | | |
| Metabolism | NgAgo possesses guided DNA nicking activity. | Lee KZ, Mechikoff MA, Kikla A, Liu A, Pandolfi P, Fitzgerald K, Gimble FS, Solomon KV. | Nucleic Acids Res | 10.1093/nar/gkab757 | 2021 | |
| Whole Body Vibration Triggers a Change in the Mutual Shaping State of Intestinal Microbiota and Body's Immunity. | Song N, Liu X, Feng Q, Xu M, Lan X, Li M, Liu R, Li C, Dong T, Wang D, Liu S. | Front Bioeng Biotechnol | 10.3389/fbioe.2019.00377 | 2019 | | |
| Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial. | Davar D, Morrison RM, Dzutsev AK, Karunamurthy A, Chauvin JM, Amatore F, Deutsch JS, Das Neves RX, Rodrigues RR, McCulloch JA, Wang H, Hartman DJ, Badger JH, Fernandes MR, Bai Y, Sun J, Cole AM, Aggarwal P, Fang JR, Deitrick C, Bao R, Duvvuri U, Sridharan SS, Kim SW, A Choudry H, Holtzman MP, Pingpank JF, O'Toole JP, DeBlasio R, Jin Y, Ding Q, Gao W, Groetsch C, Pagliano O, Rose A, Urban C, Singh J, Divarkar P, Mauro D, Bobilev D, Wooldridge J, Krieg AM, Fury MG, Whiteaker JR, Zhao L, Paulovich AG, Najjar YG, Luke JJ, Kirkwood JM, Taube JM, Park HJ, Trinchieri G, Zarour HM. | Cancer Cell | 10.1016/j.ccell.2024.10.007 | 2024 | | |
| A programmable pAgo nuclease with RNA target preference from the psychrotolerant bacterium Mucilaginibacter paludis. | Li W, Liu Y, He R, Wang L, Wang Y, Zeng W, Zhang Z, Wang F, Ma L. | Nucleic Acids Res | 10.1093/nar/gkac315 | 2022 | | |
| The diagnostic and prognostic potential of gut bacteria in inflammatory bowel disease. | Wiredu Ocansey DK, Hang S, Yuan X, Qian H, Zhou M, Valerie Olovo C, Zhang X, Mao F. | Gut Microbes | 10.1080/19490976.2023.2176118 | 2023 | | |
| Multi-omics reveal microbial determinants impacting the treatment outcome of antidepressants in major depressive disorder. | Wang Y, Zhou J, Ye J, Sun Z, He Y, Zhao Y, Ren S, Zhang G, Liu M, Zheng P, Wang G, Yang J. | Microbiome | 10.1186/s40168-023-01635-6 | 2023 | | |
| Human gut bifidobacteria inhibit the growth of the opportunistic fungal pathogen Candida albicans. | Ricci L, Mackie J, Donachie GE, Chapuis A, Mezerova K, Lenardon MD, Brown AJP, Duncan SH, Walker AW. | FEMS Microbiol Ecol | 10.1093/femsec/fiac095 | 2022 | | |
| Multi-omics profiles of the intestinal microbiome in irritable bowel syndrome and its bowel habit subtypes. | Jacobs JP, Lagishetty V, Hauer MC, Labus JS, Dong TS, Toma R, Vuyisich M, Naliboff BD, Lackner JM, Gupta A, Tillisch K, Mayer EA. | Microbiome | 10.1186/s40168-022-01450-5 | 2023 | | |
| Linkage between the intestinal microbiota and residual feed intake in broiler chickens. | Liu J, Stewart SN, Robinson K, Yang Q, Lyu W, Whitmore MA, Zhang G. | J Anim Sci Biotechnol | 10.1186/s40104-020-00542-2 | 2021 | | |
| Baseline gut microbiome composition predicts metformin therapy short-term efficacy in newly diagnosed type 2 diabetes patients. | Elbere I, Silamikelis I, Dindune II, Kalnina I, Briviba M, Zaharenko L, Silamikele L, Rovite V, Gudra D, Konrade I, Sokolovska J, Pirags V, Klovins J. | PLoS One | 10.1371/journal.pone.0241338 | 2020 | | |
| The Relationship between the Gut Microbiome and Metformin as a Key for Treating Type 2 Diabetes Mellitus. | Lee CB, Chae SU, Jo SJ, Jerng UM, Bae SK. | Int J Mol Sci | 10.3390/ijms22073566 | 2021 | | |
| Key bacterial taxa and metabolic pathways affecting gut short-chain fatty acid profiles in early life. | Tsukuda N, Yahagi K, Hara T, Watanabe Y, Matsumoto H, Mori H, Higashi K, Tsuji H, Matsumoto S, Kurokawa K, Matsuki T. | ISME J | 10.1038/s41396-021-00937-7 | 2021 | | |
| Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma. | Bjork JR, Bolte LA, Maltez Thomas A, Lee KA, Rossi N, Wind TT, Smit LM, Armanini F, Asnicar F, Blanco-Miguez A, Board R, Calbet-Llopart N, Derosa L, Dhomen N, Brooks K, Harland M, Harries M, Lorigan P, Manghi P, Marais R, Newton-Bishop J, Nezi L, Pinto F, Potrony M, Puig S, Serra-Bellver P, Shaw HM, Tamburini S, Valpione S, Waldron L, Zitvogel L, Zolfo M, de Vries EGE, Nathan P, Fehrmann RSN, Spector TD, Bataille V, Segata N, Hospers GAP, Weersma RK. | Nat Med | 10.1038/s41591-024-02803-3 | 2024 | | |
| Metabolism | A programmable omnipotent Argonaute nuclease from mesophilic bacteria Kurthia massiliensis. | Liu Y, Li W, Jiang X, Wang Y, Zhang Z, Liu Q, He R, Chen Q, Yang J, Wang L, Wang F, Ma L. | Nucleic Acids Res | 10.1093/nar/gkaa1278 | 2021 | |
| Specific gut microbiota features and metabolic markers in postmenopausal women with obesity. | Brahe LK, Le Chatelier E, Prifti E, Pons N, Kennedy S, Hansen T, Pedersen O, Astrup A, Ehrlich SD, Larsen LH. | Nutr Diabetes | 10.1038/nutd.2015.9 | 2015 | | |
| Metabolism | Puffer Fish Gut Microbiota Studies Revealed Unique Bacterial Co-Occurrence Patterns and New Insights on Tetrodotoxin Producers. | Li Z, Tian J, Lai Y, Lee CH, Cai Z, Yu CF. | Mar Drugs | 10.3390/md18050278 | 2020 | |
| Self-organized metabotyping of obese individuals identifies clusters responding differently to bariatric surgery. | Lappa D, Meijnikman AS, Krautkramer KA, Olsson LM, Aydin O, Van Rijswijk AS, Acherman YIZ, De Brauw ML, Tremaroli V, Olofsson LE, Lundqvist A, Hjorth SA, Ji B, Gerdes VEA, Groen AK, Schwartz TW, Nieuwdorp M, Backhed F, Nielsen J. | PLoS One | 10.1371/journal.pone.0279335 | 2023 | | |
| Multi-omic phenotyping reveals host-microbe responses to bariatric surgery, glycaemic control and obesity. | Penney NC, Yeung DKT, Garcia-Perez I, Posma JM, Kopytek A, Garratt B, Ashrafian H, Frost G, Marchesi JR, Purkayastha S, Hoyles L, Darzi A, Holmes E. | Commun Med (Lond) | 10.1038/s43856-022-00185-6 | 2022 | | |
| Discovery of drug-omics associations in type 2 diabetes with generative deep-learning models. | Allesoe RL, Lundgaard AT, Hernandez Medina R, Aguayo-Orozco A, Johansen J, Nissen JN, Brorsson C, Mazzoni G, Niu L, Biel JH, Leal Rodriguez C, Brasas V, Webel H, Benros ME, Pedersen AG, Chmura PJ, Jacobsen UP, Mari A, Koivula R, Mahajan A, Vinuela A, Tajes JF, Sharma S, Haid M, Hong MG, Musholt PB, De Masi F, Vogt J, Pedersen HK, Gudmundsdottir V, Gudmundsdottir V, Jones A, Kennedy G, Bell J, Thomas EL, Frost G, Thomsen H, Hansen E, Hansen TH, Hansen TH, Vestergaard H, Muilwijk M, Blom MT, 't Hart LM, Pattou F, Raverdy V, Brage S, Brage S, Kokkola T, Heggie A, McEvoy D, Mourby M, Kaye J, Hattersley A, McDonald T, Ridderstrale M, Walker M, Forgie I, Giordano GN, Pavo I, Ruetten H, Pedersen O, Hansen T, Dermitzakis E, Franks PW, Schwenk JM, Adamski J, McCarthy MI, Pearson E, Banasik K, Rasmussen S, Brunak S, IMI DIRECT Consortium. | Nat Biotechnol | 10.1038/s41587-022-01520-x | 2023 | | |
| Pathogenicity | Metformin-induced changes of the gut microbiota in healthy young men: results of a non-blinded, one-armed intervention study. | Bryrup T, Thomsen CW, Kern T, Allin KH, Brandslund I, Jorgensen NR, Vestergaard H, Hansen T, Hansen TH, Pedersen O, Nielsen T. | Diabetologia | 10.1007/s00125-019-4848-7 | 2019 | |
| Enzymology | Gut microbiota trajectory in early life may predict development of celiac disease. | Olivares M, Walker AW, Capilla A, Benitez-Paez A, Palau F, Parkhill J, Castillejo G, Sanz Y. | Microbiome | 10.1186/s40168-018-0415-6 | 2018 | |
| Genetics | Similarity of the dog and human gut microbiomes in gene content and response to diet. | Coelho LP, Kultima JR, Costea PI, Fournier C, Pan Y, Czarnecki-Maulden G, Hayward MR, Forslund SK, Schmidt TSB, Descombes P, Jackson JR, Li Q, Bork P. | Microbiome | 10.1186/s40168-018-0450-3 | 2018 | |
| Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease. | Bowerman KL, Rehman SF, Vaughan A, Lachner N, Budden KF, Kim RY, Wood DLA, Gellatly SL, Shukla SD, Wood LG, Yang IA, Wark PA, Hugenholtz P, Hansbro PM. | Nat Commun | 10.1038/s41467-020-19701-0 | 2020 | | |
| Genetic risk for autoimmunity is associated with distinct changes in the human gut microbiome. | Russell JT, Roesch LFW, Ordberg M, Ilonen J, Atkinson MA, Schatz DA, Triplett EW, Ludvigsson J. | Nat Commun | 10.1038/s41467-019-11460-x | 2019 | | |
| Genetics | Genomic and functional analysis of Romboutsia ilealis CRIBT reveals adaptation to the small intestine. | Gerritsen J, Hornung B, Renckens B, van Hijum SAFT, Martins Dos Santos VAP, Rijkers GT, Schaap PJ, de Vos WM, Smidt H. | PeerJ | 10.7717/peerj.3698 | 2017 | |
| Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade. | Andrews MC, Duong CPM, Gopalakrishnan V, Iebba V, Chen WS, Derosa L, Khan MAW, Cogdill AP, White MG, Wong MC, Ferrere G, Fluckiger A, Roberti MP, Opolon P, Alou MT, Yonekura S, Roh W, Spencer CN, Curbelo IF, Vence L, Reuben A, Johnson S, Arora R, Morad G, Lastrapes M, Baruch EN, Little L, Gumbs C, Cooper ZA, Prieto PA, Wani K, Lazar AJ, Tetzlaff MT, Hudgens CW, Callahan MK, Adamow M, Postow MA, Ariyan CE, Gaudreau PO, Nezi L, Raoult D, Mihalcioiu C, Elkrief A, Pezo RC, Haydu LE, Simon JM, Tawbi HA, McQuade J, Hwu P, Hwu WJ, Amaria RN, Burton EM, Woodman SE, Watowich S, Diab A, Patel SP, Glitza IC, Wong MK, Zhao L, Zhang J, Ajami NJ, Petrosino J, Jenq RR, Davies MA, Gershenwald JE, Futreal PA, Sharma P, Allison JP, Routy B, Zitvogel L, Wargo JA. | Nat Med | 10.1038/s41591-021-01406-6 | 2021 | | |
| Therapeutic Strategies to Modulate Gut Microbial Health: Approaches for Chronic Metabolic Disorder Management. | Rondanelli M, Borromeo S, Cavioni A, Gasparri C, Gattone I, Genovese E, Lazzarotti A, Minonne L, Moroni A, Patelli Z, Razza C, Sivieri C, Valentini EM, Barrile GC. | Metabolites | 10.3390/metabo15020127 | 2025 | | |
| Phylogeny | Characterization of Romboutsia ilealis gen. nov., sp. nov., isolated from the gastro-intestinal tract of a rat, and proposal for the reclassification of five closely related members of the genus Clostridium into the genera Romboutsia gen. nov., Intestinibacter gen. nov., Terrisporobacter gen. nov. and Asaccharospora gen. nov. | Gerritsen J, Fuentes S, Grievink W, van Niftrik L, Tindall BJ, Timmerman HM, Rijkers GT, Smidt H. | Int J Syst Evol Microbiol | 10.1099/ijs.0.059543-0 | 2014 | |
| Phylogeny | Clostridium bartlettii sp. nov., isolated from human faeces. | Song YL, Liu CX, McTeague M, Summanen P, Finegold SM | Anaerobe | 10.1016/j.anaerobe.2004.04.004 | 2004 | |
How to citeIf you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive2830.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data
License